| # | Drug | Count |
|---|---|---|
| 0 | TAPINAROF | 45 |
| 1 | MINOXIDIL | 8 |
| 2 | MINOXIDIL FOAM 5% (WOMENS) | 7 |
| 3 | RUXOLITINIB | 2 |
| 4 | TOPIRAMATE | 2 |
| 5 | ABACAVIR | 1 |
| 6 | ABACAVIR SULFATE | 1 |
| 7 | ALENDRONATE SODIUM | 1 |
| 8 | ALENDRONATE SODIUM TABLET | 1 |
| 9 | APIXABAN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAPINAROF | 45 | 0.0228 |
| 1 | GINKGO BILOBA | 1 | 0.0007 |
| 2 | INSULIN LISPRO-AABC | 1 | 0.0005 |
| 3 | CLINDAMYCIN PHOSPHATE TOPICAL | 1 | 0.0003 |
| 4 | CLINDAMYCIN PHOSPHATE | 1 | 0.0002 |
| 5 | NORETHINDRONE | 1 | 0.0002 |
| 6 | MINOXIDIL | 8 | 0.0002 |
| 7 | TRETINOIN | 1 | 0.0001 |
| 8 | ABACAVIR SULFATE | 1 | 0.0001 |
| 9 | INSULIN GLULISINE | 1 | 0.0001 |
| # | Drug class | Count |
|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 45 |
| 1 | 5-alpha Reductase Inhibitor [EPC] | 8 |
| 2 | Arteriolar Vasodilator [EPC] | 8 |
| 3 | Insulin Analog [EPC] | 2 |
| 4 | Progestin [EPC] | 2 |
| 5 | Angiotensin 2 Receptor Blocker [EPC] | 1 |
| 6 | Azole Antifungal [EPC] | 1 |
| 7 | Corticosteroid [EPC] | 1 |
| 8 | Cytochrome P450 3A Inhibitor [EPC] | 1 |
| 9 | Estrogen [EPC] | 1 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Aryl Hydrocarbon Receptor Agonist [EPC] | 45 | 0.0228 |
| 1 | Arteriolar Vasodilator [EPC] | 8 | 0.0001 |
| 2 | 5-alpha Reductase Inhibitor [EPC] | 8 | 0.0001 |
| 3 | Protease Inhibitor [EPC] | 1 | 0.0000 |
| 4 | Cytochrome P450 3A Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Progestin [EPC] | 2 | 0.0000 |
| 7 | Azole Antifungal [EPC] | 1 | 0.0000 |
| 8 | Estrogen [EPC] | 1 | 0.0000 |
| 9 | Insulin Analog [EPC] | 2 | 0.0000 |